T. Rowe Price Associates
STJ

T. Rowe Price Associates’s St Jude Medical STJ Stock Holding History

T. Rowe Price Associates’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-533,367
Closed -$42.8M – 2644
2016
Q4 		$42.8M Sell
533,367
-112,536
-17% -$8.93M 0.01% 865
2016
Q3 		$51.5M Buy
645,903
+19,529
+3% +$1.58M 0.01% 793
2016
Q2 		$48.9M Sell
626,374
-7,470
-1% -$533K 0.01% 789
2016
Q1 		$34.9M Buy
633,844
+17,976
+3% +$979K 0.01% 903
2015
Q4 		$38M Buy
615,868
+2,910
+0.5% +$184K 0.01% 865
2015
Q3 		$38.7M Sell
612,958
-103,960
-15% -$7.42M 0.01% 868
2015
Q2 		$52.4M Sell
716,918
-2,610
-0.4% -$189K 0.01% 826
2015
Q1 		$47.1M Sell
719,528
-14,199
-2% -$944K 0.01% 865
2014
Q4 		$47.7M Sell
733,727
-1,350,980
-65% -$87M 0.01% 854
2014
Q3 		$125M Sell
2,084,707
-569,490
-21% -$37.2M 0.03% 539
2014
Q2 		$184M Sell
2,654,197
-336,230
-11% -$21.8M 0.04% 463
2014
Q1 		$196M Buy
2,990,427
+86,300
+3% +$5.62M 0.04% 434
2013
Q4 		$180M Buy
2,904,127
+2,470,500
+570% +$143M 0.04% 458
2013
Q3 		$23.3M Buy
433,627
+800
+0.2% +$41.2K 0.01% 1038
2013
Q2 		$19.8M Buy
+432,827
New +$18.8M 0.01% 1070

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

T. Rowe Price Associates's STJ Position: Q1 2017 in Review

T. Rowe Price Associates sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 533,367 shares — an estimated $42.8M sold.

T. Rowe Price Associates first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $196M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • T. Rowe Price Associates reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • T. Rowe Price Associates sold 533,367 St Jude Medical shares in Q1 2017, an estimated $42.8M.
  • T. Rowe Price Associates first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • T. Rowe Price Associates's St Jude Medical position peaked at $196M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on T. Rowe Price Associates's 13F filing for Q1 2017, filed 15 May 2017.